Literature DB >> 28759332

The cellular prion protein (PrPC) as neuronal receptor for α-synuclein.

Laura Urrea1,2,3,4, Isidro Ferrer4,5,6,7, Rosalina Gavín1,2,3,4, José Antonio Del Río1,2,3,4.   

Abstract

The term 'prion-like' is used to define some misfolded protein species that propagate intercellularly, triggering protein aggregation in recipient cells. For cell binding, both direct plasma membrane interaction and membrane receptors have been described for particular amyloids. In this respect, emerging evidence demonstrates that several β-sheet enriched proteins can bind to the cellular prion protein (PrPC). Among other interactions, the physiological relevance of the binding between β-amyloid and PrPC has been a relevant focus of numerous studies. At the molecular level, published data point to the second charged cluster domain of the PrPC molecule as the relevant binding domain of the β-amyloid/PrPC interaction. In addition to β-amyloid, participation of PrPC in binding α-synuclein, responsible for neurodegenerative synucleopathies, has been reported. Although results indicate relevant participation of PrPC in the spreading of α-synuclein in living mice, the physiological relevance of the interaction remains elusive. In this comment, we focus our attention on summarizing current knowledge of PrPC as a receptor for amyloid proteins and its physiological significance, with particular focus on α-synuclein.

Entities:  

Keywords:  LAG3; Parkinson disease; PrPC; charged cluster domain; interneuronal transport; neurodegeneration; α-synuclein

Mesh:

Substances:

Year:  2017        PMID: 28759332      PMCID: PMC5553301          DOI: 10.1080/19336896.2017.1334748

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  57 in total

1.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

Authors:  L C Serpell; J Berriman; R Jakes; M Goedert; R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.

Authors:  Ulrike K Resenberger; Anja Harmeier; Andreas C Woerner; Jessica L Goodman; Veronika Müller; Rajaraman Krishnan; R Martin Vabulas; Hans A Kretzschmar; Susan Lindquist; F Ulrich Hartl; Gerd Multhaup; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  EMBO J       Date:  2011-03-25       Impact factor: 11.598

3.  Alpha-synuclein fibrils propagate through tunneling nanotubes.

Authors:  Shinya Okuda; Norihito Uemura; Ryosuke Takahashi
Journal:  Mov Disord       Date:  2017-02-20       Impact factor: 10.338

4.  Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.

Authors:  Ewa Bertrand; Waldemar Lechowicz; Grazyna M Szpak; Eliza Lewandowska; Jerzy Dymecki; Teresa Wierzba-Bobrowicz
Journal:  Folia Neuropathol       Date:  2004       Impact factor: 2.038

Review 5.  Neuroanatomy and pathology of sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Adv Anat Embryol Cell Biol       Date:  2009       Impact factor: 1.231

6.  Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.

Authors:  Erika Chung; Yong Ji; Yanjie Sun; Richard J Kascsak; Regina B Kascsak; Pankaj D Mehta; Stephen M Strittmatter; Thomas Wisniewski
Journal:  BMC Neurosci       Date:  2010-10-14       Impact factor: 3.288

7.  Single-molecule imaging reveals that small amyloid-β1-42 oligomers interact with the cellular prion protein (PrP(C)).

Authors:  Kristina A Ganzinger; Priyanka Narayan; Seema S Qamar; Laura Weimann; Rohan T Ranasinghe; Adriano Aguzzi; Christopher M Dobson; James McColl; Peter St George-Hyslop; David Klenerman
Journal:  Chembiochem       Date:  2014-10-07       Impact factor: 3.164

8.  Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology.

Authors:  Megan E Larson; Mathew A Sherman; Susan Greimel; Michael Kuskowski; Julie A Schneider; David A Bennett; Sylvain E Lesné
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

Review 9.  Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.

Authors:  Michel Goedert; Masami Masuda-Suzukake; Benjamin Falcon
Journal:  Brain       Date:  2016-09-21       Impact factor: 13.501

10.  Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.

Authors:  Maria E Bernis; Julius T Babila; Sara Breid; Katharina Annick Wüsten; Ullrich Wüllner; Gültekin Tamgüney
Journal:  Acta Neuropathol Commun       Date:  2015-11-26       Impact factor: 7.801

View more
  10 in total

1.  Parkinson's Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1.

Authors:  Jolene Su Yi Tan; Bernett Lee; Jackwee Lim; Dong Rui Ma; Jia Xin Goh; Suh Yee Goh; Muhammad Yaaseen Gulam; Ser Mei Koh; Weiling Wendy Lee; Lei Feng; Qing Wang; Yinxia Chao; Olaf Rötzschke; Eng King Tan
Journal:  Cells       Date:  2022-05-16       Impact factor: 7.666

2.  Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.

Authors:  Luise Linsenmeier; Behnam Mohammadi; Sebastian Wetzel; Berta Puig; Walker S Jackson; Alexander Hartmann; Keiji Uchiyama; Suehiro Sakaguchi; Kristina Endres; Jörg Tatzelt; Paul Saftig; Markus Glatzel; Hermann C Altmeppen
Journal:  Mol Neurodegener       Date:  2018-04-06       Impact factor: 14.195

3.  Identification of N-linked glycans as specific mediators of neuronal uptake of acetylated α-Synuclein.

Authors:  Melissa Birol; Slawomir P Wojcik; Andrew D Miranker; Elizabeth Rhoades
Journal:  PLoS Biol       Date:  2019-06-18       Impact factor: 8.029

Review 4.  The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain.

Authors:  Rosalina Gavín; Laia Lidón; Isidre Ferrer; José Antonio Del Río
Journal:  Cells       Date:  2020-03-02       Impact factor: 6.600

Review 5.  Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson's Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Chiara Villa; Mohd Farooq Shaikh; Christina Piperi
Journal:  Biology (Basel)       Date:  2020-04-23

Review 6.  Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.

Authors:  Loredana Leggio; Greta Paternò; Silvia Vivarelli; Francesca L'Episcopo; Cataldo Tirolo; Gabriele Raciti; Fabrizio Pappalardo; Carmela Giachino; Salvatore Caniglia; Maria Francesca Serapide; Bianca Marchetti; Nunzio Iraci
Journal:  Biomolecules       Date:  2020-09-16

7.  On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases.

Authors:  Giuseppe Legname; Carlo Scialò
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

8.  The Cellular Prion Protein Increases the Uptake and Toxicity of TDP-43 Fibrils.

Authors:  Carlo Scialò; Luigi Celauro; Marco Zattoni; Thanh Hoa Tran; Edoardo Bistaffa; Fabio Moda; Robert Kammerer; Emanuele Buratti; Giuseppe Legname
Journal:  Viruses       Date:  2021-08-17       Impact factor: 5.048

9.  Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.

Authors:  Makoto Hashimoto; Gilbert Ho; Yoshiki Takamatsu; Ryoko Wada; Shuei Sugama; Masaaki Waragai; Eliezer Masliah; Takato Takenouchi
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

Review 10.  Cellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction.

Authors:  Hajar Miranzadeh Mahabadi; Changiz Taghibiglou
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.